BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24781208)

  • 1. Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.
    Lu A; Poddar M; Tang Y; Proto JD; Sohn J; Mu X; Oyster N; Wang B; Huard J
    Hum Mol Genet; 2014 Sep; 23(18):4786-800. PubMed ID: 24781208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
    Sohn J; Lu A; Tang Y; Wang B; Huard J
    Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.
    Mu X; Tang Y; Lu A; Takayama K; Usas A; Wang B; Weiss K; Huard J
    Hum Mol Genet; 2015 May; 24(10):2923-37. PubMed ID: 25678553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
    Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
    Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
    Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
    J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
    Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
    Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
    Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
    Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
    Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
    J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.
    Mu X; Usas A; Tang Y; Lu A; Wang B; Weiss K; Huard J
    FASEB J; 2013 Sep; 27(9):3619-31. PubMed ID: 23704088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
    Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
    Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
    Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
    J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.
    Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ
    Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
    Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
    EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
    Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
    Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.
    Salvadori L; Chiappalupi S; Arato I; Mancuso F; Calvitti M; Marchetti MC; Riuzzi F; Calafiore R; Luca G; Sorci G
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.